Details for New Drug Application (NDA): 206788
✉ Email this page to a colleague
NDA 206788 describes ELTROMBOPAG OLAMINE, which is a drug marketed by Annora Pharma and Hetero Labs Ltd V and is included in two NDAs. Additional details are available on the ELTROMBOPAG OLAMINE profile page.
The generic ingredient in ELTROMBOPAG OLAMINE is eltrombopag olamine. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eltrombopag olamine profile page.
The generic ingredient in ELTROMBOPAG OLAMINE is eltrombopag olamine. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eltrombopag olamine profile page.
Summary for 206788
| Tradename: | ELTROMBOPAG OLAMINE |
| Applicant: | Hetero Labs Ltd V |
| Ingredient: | eltrombopag olamine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 12.5MG ACID | ||||
| Approval Date: | Jan 17, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG ACID | ||||
| Approval Date: | Jan 17, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG ACID | ||||
| Approval Date: | Jan 17, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
